A case is presented of a 22 year-old woman with genital Chlamydia trachomatis infection, which persisted for 8 months despite treatment with four 1g doses of azithromycin and both a 7-day and 14-day course of doxycycline. She denied any sexual contact during this time. Tests for other infections including extragenital sites were negative.
KongFYHockingJS.Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect Dis2015;
15: 293.
2.
SomaniJBhullarVBWorkowskiKA, et al.
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis2000;
181: 1421–1427.
3.
KongFTabriziSNFairleyCK, et al.
The efficacy of Azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother2015;
70: 1290–1297.
4.
SandozKMRockeyDD.Antibiotic resistance in Chlamydiae. Future Microbiol2010;
5: 1427–1442.
5.
O’NeillCESeth-SmithHMVan Der PolB, et al.
Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology2013;
159: 748–756.
6.
PittRAlexanderSIsonC, et al.
Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections. J Antimicrob Chemother2018;
73: 680–686.
7.
ChandraNBroadCFolkardK, et al.
Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis. Sex Transm Infect2018;
94: 320–326.
